Tirzepatide Tirzepatide is a newer medication that works as a dual GIP/GLP-1 receptor agonist, targeting two hormones involved in appetite and blood sugar regulation
Odole 4 , Janice Victor 1 , Jon Doan 1 , Toyin Bello 2 , Oye Gureje 2 , Oluwagbohunmi A
Thank you, CitizenMeds, for your support and for making this possible for me
A systematic review published in Addictive Behaviors found that 15 to 20% of patients stopping long-term SSRI therapy experience clinically significant discontinuation syndrome
It is not strictly unexplored, nor is it a failed target
Before your first semaglutide GLP-1 shot, its important to be aware of potential side effects